Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Turnover | 5.92%1.47B | --554.55M | -15.13%1.39B | 102.71%1.63B | 140.91%1.34B | -47.90%806.26M | --554.83M | --1.55B |
| Operating income | 5.92%1.47B | 554.55M | -15.13%1.39B | 102.71%1.63B | 140.91%1.34B | -47.90%806.26M | 554.83M | 1.55B |
| Cost of sales | -14.94%-986.4M | ---357.94M | 20.73%-858.21M | -105.88%-1.08B | -151.15%-902.88M | 51.63%-525.84M | ---359.49M | ---1.09B |
| Operating expenses | -14.94%-986.4M | -357.94M | 20.73%-858.21M | -105.88%-1.08B | -151.15%-902.88M | 51.63%-525.84M | -359.49M | -1.09B |
| Gross profit | -8.70%482.85M | 196.61M | -4.15%528.88M | 96.78%551.8M | 122.06%433.77M | -39.12%280.42M | 195.34M | 460.61M |
| Selling expenses | -1.26%-138M | ---61.11M | 2.21%-136.29M | -41.95%-139.36M | -41.38%-100.7M | 20.03%-98.17M | ---71.22M | ---122.76M |
| Administrative expenses | 13.23%-85.05M | ---53.29M | -16.58%-98.02M | -53.11%-84.08M | -25.48%-50.97M | 4.58%-54.92M | ---40.62M | ---57.55M |
| Research and development expenses | 4.98%-48.42M | ---22.95M | 16.57%-50.96M | -14.15%-61.08M | -16.31%-47.46M | -31.74%-53.51M | ---40.81M | ---40.62M |
| Impairment and provision | 48.23%-498K | ---312K | 45.83%-962K | -1,700.00%-1.78M | -444.19%-740K | 115.77%111K | --215K | ---704K |
| -Other impairment is provision | 48.23%-498K | ---312K | 45.83%-962K | -1,700.00%-1.78M | -444.19%-740K | 115.77%111K | --215K | ---704K |
| Special items of operating profit | -4.44%13.08M | --2.67M | 5.89%13.68M | -4.41%12.92M | -7.31%10.35M | 50.11%13.52M | --11.17M | --9.01M |
| Operating profit | -12.63%223.96M | 61.62M | -7.93%256.34M | 218.39%278.43M | 351.73%244.25M | -64.74%87.45M | 54.07M | 247.99M |
| Financing cost | -115.89%-557K | ---222K | 44.03%-258K | 0.65%-461K | -19.23%-372K | -0.43%-464K | ---312K | ---462K |
| Share of profits of associates | -127.07%-2.8M | ---2.46M | -1,745.33%-1.23M | -76.04%75K | 22.75%1.11M | 6.46%313K | --901K | --294K |
| Special items of earning before tax | 279.41%619.02M | --619.02M | 40.95%-345.04M | -1,049.28%-584.34M | -576.78%-488.34M | 115.52%61.56M | --102.43M | ---396.59M |
| Earning before tax | 1,030.94%839.62M | 677.96M | 70.55%-90.19M | -305.77%-306.3M | -254.92%-243.36M | 200.06%148.85M | 157.08M | -148.77M |
| Tax | -1.35%-46.03M | ---13.39M | 9.00%-45.42M | -179.35%-49.91M | -379.28%-43.7M | 67.77%-17.87M | ---9.12M | ---55.44M |
| After-tax profit from continuing operations | 685.20%793.58M | 664.56M | 61.93%-135.61M | -371.94%-356.21M | -294.00%-287.06M | 164.14%130.99M | 147.97M | -204.21M |
| Earning after tax | 685.20%793.58M | 664.56M | 61.93%-135.61M | -371.94%-356.21M | -294.00%-287.06M | 164.14%130.99M | 147.97M | -204.21M |
| Minority profit | -47.53%266K | --304K | 1,226.67%507K | -142.45%-45K | -28.57%15K | 2,750.00%106K | --21K | ---4K |
| Profit attributable to shareholders | 682.82%793.32M | 664.26M | 61.78%-136.12M | -372.13%-356.16M | -294.04%-287.07M | 164.09%130.88M | 147.94M | -204.2M |
| Basic earnings per share | 379.76%4.7 | 5.93 | -1.68 | |||||
| Diluted earnings per share | 159.52%1 | 0.22 | -1.68 | |||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | KPMG | -- | KPMG | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.